Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules

Clinical Genitourinary Cancer · Published 2025-01-01 · Journal article · DOI 10.1016/j.clgc.2026.102577

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.clgc.2026.102577

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles